Hederagenin Attenuates Cerebral Ischaemia/Reperfusion Injury by Regulating MLK3 Signalling.

Yu, Hailong; Song, Lilong; Cao, Xiang; Li, Wei; Zhao, Yuanyuan; Chen, Jian; Li, Jun; Chen, Yingzhu; Yu, Wenkui; Xu, Yun

Yu, Hailong; Song, Lilong; Cao, Xiang; Li, Wei; Zhao, Yuanyuan; Chen, Jian; Li, Jun; Chen, Yingzhu; Yu, Wenkui; Xu, Yun.

Afiliación

Yu H; Affiliated of Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Song L; Clinical Medical College of Yangzhou University, Yangzhou, China.
Cao X; Department of Neurology, Northern Jiangsu People's Hospital, Yangzhou, China.
Li W; Department of Neurology, Northern Jiangsu People's Hospital, Yangzhou, China.
Zhao Y; Dalian Medical University, Dalian, China.
Chen J; Affiliated of Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Li J; Department of Neurology, Northern Jiangsu People's Hospital, Yangzhou, China.
Chen Y; Dalian Medical University, Dalian, China.
Yu W; Department of Neurology, Northern Jiangsu People's Hospital, Yangzhou, China.
Xu Y; Dalian Medical University, Dalian, China.

Front Pharmacol ; 11: 1173, 2020.

Article en En | MEDLINE | ID: mdl-32848779

Palabras clave

MLK3 signalling pathway; apoptosis; cerebral ischaemia/reperfusion injury; hederagenin; inflammation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google